Cancer Case Studies - Akbar Khan, MD (2021 Conference) (LDN, low dose naltrexone)
Cancer is a systemic disease. This presentation is on using low dose naltrexone (LDN) as a cancer treatment, looking at several case reports, diagnostic tests, and various therapies. Cases include breast cancer, nodular melanoma, and adenocarcinoma with lymphovascular invasion in a colonic polyp
KEYWORDS: low dose naltrexone (LDN), endogenous opiates, breast cancer, hormone, nodular melanoma, prostate cancer, adenocarcinoma
This is a summary of the presentation. Click on the video for full information.